# Optimized Expansion of the Implanted Transcatheter Aortic Valve

> **NCT07042529** · NA · RECRUITING · sponsor: **Ole De Backer** · enrollment: 620 (estimated)

## Conditions studied

- Aortic Stenosis Disease
- Valvular Heart Disease

## Interventions

- **PROCEDURE:** OptEx-TAVI
- **PROCEDURE:** SoC-TAVI

## Key facts

- **NCT ID:** NCT07042529
- **Lead sponsor:** Ole De Backer
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-05
- **Primary completion:** 2032-07-01
- **Final completion:** 2033-07-01
- **Target enrollment:** 620 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07042529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07042529, "Optimized Expansion of the Implanted Transcatheter Aortic Valve". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07042529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*